Liposomal sustained-release delivery systems for intravenous injection. IV. Antitumor activity of newly synthesized lipophilic 1-beta-D-arabinofuranosylcytosine prodrug-bearing liposomes.
Tokunaga
Y
Y
Iwasa
T
T
Fujisaki
J
J
Sawai
S
S
Kagayama
A
A
D000818:Animals; D003561:Cytarabine / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology*; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008081:Liposomes; D051379:Mice; D008811:Mice, Inbred DBA; D008813:Mice, Inbred ICR; D011355:Prodrugs
D003692:Delayed-Action Preparations; D008081:Liposomes; D011355:Prodrugs; D003561:Cytarabine